Exact Mass: 473.1739328

Exact Mass Matches: 473.1739328

Found 445 metabolites which its exact mass value is equals to given mass value 473.1739328, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(6R)-Folinic acid

2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid

C20H23N7O7 (473.1658888)

The active metabolite of folic acid. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. [HMDB] D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1]. Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1].

Raloxifene

(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone

C28H27NO4S (473.1660702000001)

Raloxifene is only found in individuals that have used or taken this drug. It is a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue. [PubChem]. Raloxifene binds to estrogen receptors, resulting in differential expression of multiple estrogen-regulated genes in different tissues. Raloxifene produces estrogen-like effects on bone, reducing resorption of bone and increasing bone mineral density in postmenopausal women, thus slowing the rate of bone loss. The maintenance of bone mass by raloxifene and estrogens is, in part, through the regulation of the gene-encoding transforming growth factor-β3 (TGF-β3), which is a bone matrix protein with antiosteoclastic properties. Raloxifene activates TGF-β3 through pathways that are estrogen receptor-mediated but involve DNA sequences distinct from the estrogen response element. The drug also binds to the estrogen receptor and acts as an estrogen agonist in preosteoclastic cells, which results in the inhibtion of their proliferative capacity. This inhibition is thought to contribute to the drugs effect on bone resorption. Other mechanisms include the suppression of activity of the bone-resorbing cytokine interleukin-6 promoter activity. Raloxifene also antagonizes the effects of estrogen on mammary tissue and blocks uterotrophic responses to estrogen. By competing with estrogens for the estrogen receptors in reproductive tissue, raloxifene prevents the transcriptional activation of genes containing the estrogen response element. As well, raloxifene inhibits the estradiol-dependent proliferation of MCF-7 human mammary tumor cells in vitro. The mechansim of action of raloxifene has not been fully determined, but evidence suggests that the drugs tissue-specific estrogen agonist or antagonist activity is related to the structural differences between the raloxifene-estrogen receptor complex (specifically the surface topography of AF-2) and the estrogen-estrogen receptor complex. Also, the existence of at least 2 estrogen receptors (ERα, ERβ) may contribute to the tissue specificity of raloxifene. CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3671; ORIGINAL_PRECURSOR_SCAN_NO 3667 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7479; ORIGINAL_PRECURSOR_SCAN_NO 7477 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3606; ORIGINAL_PRECURSOR_SCAN_NO 3604 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3605; ORIGINAL_PRECURSOR_SCAN_NO 3603 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7456; ORIGINAL_PRECURSOR_SCAN_NO 7455 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7507; ORIGINAL_PRECURSOR_SCAN_NO 7505 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7491; ORIGINAL_PRECURSOR_SCAN_NO 7487 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7503; ORIGINAL_PRECURSOR_SCAN_NO 7502 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7515; ORIGINAL_PRECURSOR_SCAN_NO 7513 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3597; ORIGINAL_PRECURSOR_SCAN_NO 3594 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3612; ORIGINAL_PRECURSOR_SCAN_NO 3610 CONFIDENCE standard compound; INTERNAL_ID 236; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3602; ORIGINAL_PRECURSOR_SCAN_NO 3597 G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XC - Selective estrogen receptor modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist CONFIDENCE standard compound; INTERNAL_ID 2754 CONFIDENCE standard compound; INTERNAL_ID 8536 D050071 - Bone Density Conservation Agents C1892 - Chemopreventive Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Raloxifene (Keoxifene) is a benzothiophene-derived selective estrogen receptor modulator (SERM). Raloxifene has estrogen-agonistic effects on bone and lipids and estrogen-antagonistic effects on the breast and uterus. Raloxifene is used for breast cancer and osteoporosis research[1].

10-Formyltetrahydrofolate

(2S)-2-[(4-{N-[(4-hydroxy-2-imino-5,6,7,8-tetrahydro-1H-pteridin-6-yl)methyl]formamido}phenyl)formamido]pentanedioic acid

C20H23N7O7 (473.1658888)

10-formyltetrahydrofolate, also known as 10-formyl-thf or 10-formyltetrahydropteroylglutamic acid, is a member of the class of compounds known as tetrahydrofolic acids. Tetrahydrofolic acids are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit. 10-formyltetrahydrofolate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). 10-formyltetrahydrofolate can be found in a number of food items such as agave, black salsify, white cabbage, and lemon, which makes 10-formyltetrahydrofolate a potential biomarker for the consumption of these food products. 10-formyltetrahydrofolate exists in all eukaryotes, ranging from yeast to humans. In humans, 10-formyltetrahydrofolate is involved in several metabolic pathways, some of which include mercaptopurine action pathway, methionine metabolism, purine metabolism, and folate malabsorption, hereditary. 10-formyltetrahydrofolate is also involved in several metabolic disorders, some of which include myoadenylate deaminase deficiency, adenine phosphoribosyltransferase deficiency (APRT), molybdenum cofactor deficiency, and cystathionine beta-synthase deficiency. 10-Formyltetrahydrofolate (10-CHO-THF) is a form of tetrahydrofolate that acts as a donor of formyl groups in anabolism. In these reactions 10-CHO-THF is used as a substrate in formyltransferase reactions. This is important in purine biosynthesis, where 10-CHO-THF is a substrate for phosphoribosylaminoimidazolecarboxamide formyltransferase, as well as in the formylation of the methionyl initiator tRNA (fMet-tRNA), when 10-CHO-THF is a substrate for methionyl-tRNA formyltransferase . 10-Formyltetrahydrofolate (10-CHO-THF) is form of tetrahydrofolate that acts as a donor of formyl groups in anabolism. In particular, 10-CHO-THF is used as a substrate in a number of formyltransferase reactions. It plays an important role in purine biosynthesis, where 10-CHO-THF is a substrate for phosphoribosylaminoimidazolecarboxamide formyltransferase, as well as in the formylation of the methionyl initiator tRNA (fMet-tRNA), when 10-CHO-THF is a substrate for methionyl-tRNA formyltransferase. 10-Formyltetrahydrofolate is a substrate for Trifunctional purine biosynthetic protein adenosine-3, Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase (mitochondrial), 10-formyltetrahydrofolate dehydrogenase, Folylpolyglutamate synthase (mitochondrial), Bifunctional purine biosynthesis protein PURH and C-1-tetrahydrofolate synthase (cytoplasmic).

Proteacin

C20H27NO12 (473.15331820000006)

Senampeline C

C25H31NO8 (473.2049566)

OA-6129B1

(5R,6R)-3-[2-[3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-6-[(1S)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C20H31N3O8S (473.1831766)

Temsavir

BMS-626529

C24H23N7O4 (473.18114380000003)

C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

OA-6129 B2

(5R,6S)-3-[2-[3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-6-[(1S)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C20H31N3O8S (473.1831766)

4-Tert-butyl-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide

C23H27N3O6S (473.1620482000001)

D065128 - Endothelin Receptor Antagonists Ro 46-2005 is a novel synthetic non-peptide endothelin receptor antagonist, inhibits the specific binding of 125I-ET-1 to human vascular smooth muscle cells (ETA receptor) with IC50 of 220 nM. IC50 value: 220 nM (ETA) [2] Target: Endothelin in vitro: Ro 46-2005 proves to be equipotent (IC50 200-500 nM) for inhibition of [125I]ET-1 binding on the two known ET receptor subtypes (ETA and ETB). Ro 46-2005 also inhibits the functional consequences of ET-1 stimulation: the ET-l-induced release of arachidonic acid from rat mesangial cells was inhibited with an IC50 of 1.8 μM.[1]

Folinic acid

(2S)-2-{[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioic acid

C20H23N7O7 (473.1658888)

(6S)-5-formyltetrahydrofolic acid is the pharmacologically active (6S)-stereoisomer of 5-formyltetrahydrofolic acid. It has a role as an antineoplastic agent and a metabolite. It is a conjugate acid of a (6S)-5-formyltetrahydrofolate(2-). Levoleucovorin is the enantiomerically active form of Folinic Acid (also known as 5-formyl tetrahydrofolic acid or leucovorin). Commercially available leucovorin is composed of a 1:1 racemic mixture of the dextrorotary and levorotary isomers, while levoleucovorin contains only the pharmacologically active levo-isomer. In vitro, the levo-isomer has been shown to be rapidly converted to the biologically available methyl-tetrahydrofolate form while the dextro form is slowly excreted by the kidneys. Despite this difference in activity, the two commercially available forms have been shown to be pharmacokinetically identical and may be used interchangeably with limited differences in efficacy or side effects (Kovoor et al, 2009). As folate analogs, levoleucovorin and leucovorin are both used to counteract the toxic effects of folic acid antagonists, such as methotrexate, which act by inhibiting the enzyme dihydrofolate reductase (DHFR). They are indicated for use as rescue therapy following use of high-dose methotrexate in the treatment of osteosarcoma or for diminishing the toxicity associated with inadvertent overdosage of folic acid antagonists. Levoleucovorin, as the product Fusilev (FDA), has an additional indication for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer. Folic acid is an essential B vitamin required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. However, in order to function in this role, it must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted when high-dose methotrexate is used for cancer therapy. As methotrexate functions as a DHFR inhibitor to prevent DNA synthesis in rapidly dividing cells, it also prevents the formation of DHF and THF. This results in a deficiency of coenzymes and a resultant buildup of toxic substances that are responsible for numerous adverse side effects of methotrexate therapy. As levoleucovorin and leucovorin are analogs of tetrahydrofolate (THF), they are able to bypass DHFR reduction and act as a cellular replacement for the co-factor THF, thereby preventing these toxic side effects. Levoleucovorin is a Folate Analog. Levoleucovorin is a natural product found in Homo sapiens with data available. Levoleucovorin is the active l-isomer of the racemic mixture of the 5-formyl derivative of tetrahydrofolic acid. Metabolically active, l-leucovorin, also known levoleucovorin, does not require bioactivation by dihydrofolate reductase, an enzyme inhibited by folic acid antagonists. This agent may enhance the effects of fluoropyrimidines by stabilizing their binding to the enzyme thymidylate synthase. (NCI04) 5-Formyltetrahydrofolic acid is a metabolite found in or produced by Saccharomyces cerevisiae. A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN. See also: Levoleucovorin Calcium (active moiety of); Levoleucovorin disodium (active moiety of). Folinic acid (CAS: 58-05-9), also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate (a chemotherapy agent and immune system suppressant) and pyrimethamine (Wikipedia). Folinic acid is the active metabolite of folic acid. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1]. Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1].

Dhurrin 6'-glucoside

2-(4-hydroxyphenyl)-2-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile

C20H27NO12 (473.15331820000006)

Dhurrin 6-glucoside is found in cereals and cereal products. Dhurrin 6-glucoside is a constituent of Sorghum bicolor (sorghum)

Pteroyl-D-glutamic acid

(2R)-2-[(4-{[(2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid

C20H23N7O7 (473.1658888)

The active metabolite of Folic acid, is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. Folic acid, a water-soluble B-complex vitamin, is found in foods such as liver, kidneys, yeast, and leafy, green vegetables. Folic acid is used to diagnose folate deficiency and to treat topical sprue and megaloblastic and macrocytic anemias, hematologic complications resulting from a deficiency in folic acid. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. The active metabolite of Folic acid, is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid.

CD 1790

7-(but-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C25H27N7O3 (473.21752720000006)

CD 1790 is a metabolite of linagliptin. Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly. (Wikipedia)

4-Tert-butyl-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide

4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)pyrimidin-4-yl]benzene-1-sulfonamide

C23H27N3O6S (473.1620482000001)

Mefox

2-({4-[({2-amino-8-methyl-4,9-dioxo-4H,6H,7H,8H,9H-pyrazino[1,2-a][1,3,5]triazin-7-yl}methyl)amino]phenyl}formamido)pentanedioic acid

C20H23N7O7 (473.1658888)

Temsavir

1-(4-benzoylpiperazin-1-yl)-2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]ethane-1,2-dione

C24H23N7O4 (473.18114380000003)

C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

Enasidenib

2-methyl-1-({4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl}amino)propan-2-ol

C19H17F6N7O (473.1398704)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C137826 - Isocitrate Dehydrogenase Inhibitor > C168619 - IDH2 inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.

Formyltetrahydrofolate

2-[(4-{[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methyl]amino}phenyl)formamido]-5-(formyloxy)-5-oxopentanoic acid

C20H23N7O7 (473.1658888)

Ketotrexate

2-[(4-{[2-(2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)ethyl]amino}phenyl)formamido]pentanedioic acid

C21H27N7O6 (473.20227220000004)

Lixivaptan

N-(3-chloro-4-{3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),4,6,11,13-pentaene-9-carbonyl}phenyl)-5-fluoro-2-methylbenzamide

C27H21ClFN3O2 (473.1306248)

C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist

quinoneimine

4-[(6-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexa-2,4-dien-1-ylidene)amino]-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one

C23H27N3O8 (473.17980620000003)

2-[[4-[(2-Amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]-4-formylpentanedioic acid

2-[(4-{[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methyl]amino}phenyl)formamido]-4-formylpentanedioic acid

C20H23N7O7 (473.1658888)

Desmethylmyxothiazole

Cys His Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-hydroxypropanoic acid

C18H31N7O6S (473.20564260000003)

Cys His Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C17H27N7O7S (473.1692592)

Cys His Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C17H27N7O7S (473.1692592)

Cys His Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]hexanoic acid

C18H31N7O6S (473.20564260000003)

Cys His Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C17H27N7O7S (473.1692592)

Cys His Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C17H27N7O7S (473.1692592)

Cys Lys His Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H31N7O6S (473.20564260000003)

Cys Lys Ser His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O6S (473.20564260000003)

Cys Asn His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C17H27N7O7S (473.1692592)

Cys Asn Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Cys Gln His Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C17H27N7O7S (473.1692592)

Cys Gln Ser His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Cys Ser His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C18H31N7O6S (473.20564260000003)

Cys Ser His Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C17H27N7O7S (473.1692592)

Cys Ser Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O6S (473.20564260000003)

Cys Ser Gln His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Cys Thr His Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C17H27N7O7S (473.1692592)

Cys Thr Asn His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Asp Asp Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Asp Asp Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C19H31N5O9 (473.21216760000004)

Asp Asp Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C18H27N5O10 (473.17578419999995)

Asp Asp Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Asp Glu Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carboxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Asp Glu Pro Asn

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-5-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H27N5O10 (473.17578419999995)

Asp Gly Pro Trp

(3S)-3-amino-3-({2-[(2S)-2-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)propanoic acid

C22H27N5O7 (473.19103920000003)

Asp Gly Trp Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C22H27N5O7 (473.19103920000003)

Asp Lys Asp Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Asp Lys Pro Asp

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-carboxypropanamido]hexanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C19H31N5O9 (473.21216760000004)

Asp Asn Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Asp Asn Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C18H27N5O10 (473.17578419999995)

Asp Pro Asp Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]hexanoic acid

C19H31N5O9 (473.21216760000004)

Asp Pro Asp Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-4-carbamoylbutanoic acid

C18H27N5O10 (473.17578419999995)

Asp Pro Glu Asn

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C18H27N5O10 (473.17578419999995)

Asp Pro Gly Trp

(3S)-3-amino-4-[(2S)-2-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C22H27N5O7 (473.19103920000003)

Asp Pro Lys Asp

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}hexanamido]butanedioic acid

C19H31N5O9 (473.21216760000004)

Asp Pro Asn Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]pentanedioic acid

C18H27N5O10 (473.17578419999995)

Asp Pro Gln Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]butanedioic acid

C18H27N5O10 (473.17578419999995)

Asp Pro Arg Ser

(3S)-3-amino-4-[(2S)-2-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C18H31N7O8 (473.2234006)

Asp Pro Ser Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C18H31N7O8 (473.2234006)

Asp Pro Trp Gly

(3S)-3-amino-4-[(2S)-2-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C22H27N5O7 (473.19103920000003)

Asp Gln Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Asp Gln Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H27N5O10 (473.17578419999995)

Asp Arg Pro Ser

(3S)-3-amino-3-{[(2S)-5-carbamimidamido-1-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopentan-2-yl]carbamoyl}propanoic acid

C18H31N7O8 (473.2234006)

Asp Arg Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C18H31N7O8 (473.2234006)

Asp Ser Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C18H31N7O8 (473.2234006)

Asp Ser Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C18H31N7O8 (473.2234006)

Asp Trp Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]acetyl}pyrrolidine-2-carboxylic acid

C22H27N5O7 (473.19103920000003)

Asp Trp Pro Gly

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl}propanoic acid

C22H27N5O7 (473.19103920000003)

Glu Asp Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Glu Asp Pro Asn

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-3-carboxy-1-oxopropan-2-yl]carbamoyl}butanoic acid

C18H27N5O10 (473.17578419999995)

Glu Asn Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Glu Asn Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H27N5O10 (473.17578419999995)

Glu Pro Asp Asn

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C18H27N5O10 (473.17578419999995)

Glu Pro Asn Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]butanedioic acid

C18H27N5O10 (473.17578419999995)

Glu Pro Gln Thr

(4S)-4-amino-5-[(2S)-2-{[(1S)-3-carbamoyl-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}propyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H31N5O9 (473.21216760000004)

Glu Pro Thr Gln

(4S)-4-amino-5-[(2S)-2-{[(1S,2R)-1-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H31N5O9 (473.21216760000004)

Glu Gln Pro Thr

(4S)-4-amino-4-{[(2S)-4-carbamoyl-1-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}butanoic acid

C19H31N5O9 (473.21216760000004)

Glu Gln Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Glu Thr Pro Gln

(4S)-4-amino-4-{[(2S,3R)-1-[(2S)-2-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]carbamoyl}butanoic acid

C19H31N5O9 (473.21216760000004)

Glu Thr Gln Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxybutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Phe Gly His Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C21H27N7O6 (473.20227220000004)

Phe Gly Asn His

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H27N7O6 (473.20227220000004)

Phe His Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-carbamoylpropanoic acid

C21H27N7O6 (473.20227220000004)

Phe His Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]acetic acid

C21H27N7O6 (473.20227220000004)

Phe Asn Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C21H27N7O6 (473.20227220000004)

Phe Asn His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C21H27N7O6 (473.20227220000004)

Gly Asp Pro Trp

(3S)-3-(2-aminoacetamido)-4-[(2S)-2-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C22H27N5O7 (473.19103920000003)

Gly Asp Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C22H27N5O7 (473.19103920000003)

Gly Phe His Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C21H27N7O6 (473.20227220000004)

Gly Phe Asn His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H27N7O6 (473.20227220000004)

Gly His Phe Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C21H27N7O6 (473.20227220000004)

Gly His Asn Phe

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C21H27N7O6 (473.20227220000004)

Gly Asn Phe His

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H27N7O6 (473.20227220000004)

Gly Asn His Phe

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C21H27N7O6 (473.20227220000004)

Gly Pro Asp Trp

(3S)-3-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C22H27N5O7 (473.19103920000003)

Gly Pro Trp Asp

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]butanedioic acid

C22H27N5O7 (473.19103920000003)

Gly Trp Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C22H27N5O7 (473.19103920000003)

Gly Trp Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C22H27N5O7 (473.19103920000003)

His Cys Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]hexanamido]-3-hydroxypropanoic acid

C18H31N7O6S (473.20564260000003)

His Cys Asn Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C17H27N7O7S (473.1692592)

His Cys Gln Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C17H27N7O7S (473.1692592)

His Cys Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]hexanoic acid

C18H31N7O6S (473.20564260000003)

His Cys Ser Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C17H27N7O7S (473.1692592)

His Cys Thr Asn

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C17H27N7O7S (473.1692592)

His Phe Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]acetamido}-3-carbamoylpropanoic acid

C21H27N7O6 (473.20227220000004)

His Phe Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]acetic acid

C21H27N7O6 (473.20227220000004)

His Gly Phe Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-phenylpropanamido]-3-carbamoylpropanoic acid

C21H27N7O6 (473.20227220000004)

His Gly Asn Phe

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-carbamoylpropanamido]-3-phenylpropanoic acid

C21H27N7O6 (473.20227220000004)

His Lys Cys Ser

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C18H31N7O6S (473.20564260000003)

His Lys Ser Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C18H31N7O6S (473.20564260000003)

His Asn Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C17H27N7O7S (473.1692592)

His Asn Phe Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]acetic acid

C21H27N7O6 (473.20227220000004)

His Asn Gly Phe

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]acetamido}-3-phenylpropanoic acid

C21H27N7O6 (473.20227220000004)

His Asn Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

His Gln Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C17H27N7O7S (473.1692592)

His Gln Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

His Ser Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanoic acid

C18H31N7O6S (473.20564260000003)

His Ser Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C17H27N7O7S (473.1692592)

His Ser Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanoic acid

C18H31N7O6S (473.20564260000003)

His Ser Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

His Thr Cys Asn

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C17H27N7O7S (473.1692592)

His Thr Asn Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Ile Asn Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Lys Cys His Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H31N7O6S (473.20564260000003)

Lys Cys Ser His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O6S (473.20564260000003)

Lys Asp Asp Pro

(2S)-1-[(2S)-3-carboxy-2-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Lys Asp Pro Asp

(2S)-2-{[(2S)-1-[(2S)-3-carboxy-2-[(2S)-2,6-diaminohexanamido]propanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C19H31N5O9 (473.21216760000004)

Lys His Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C18H31N7O6S (473.20564260000003)

Lys His Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C18H31N7O6S (473.20564260000003)

Lys Pro Asp Asp

(2S)-2-[(2S)-3-carboxy-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}propanamido]butanedioic acid

C19H31N5O9 (473.21216760000004)

Lys Ser Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O6S (473.20564260000003)

Lys Ser His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C18H31N7O6S (473.20564260000003)

Leu Asn Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Asn Cys His Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C17H27N7O7S (473.1692592)

Asn Cys Thr His

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Asn Asp Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Asn Asp Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C18H27N5O10 (473.17578419999995)

Asn Glu Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Asn Glu Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H27N5O10 (473.17578419999995)

Asn Phe Gly His

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C21H27N7O6 (473.20227220000004)

Asn Phe His Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C21H27N7O6 (473.20227220000004)

Asn Gly Phe His

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H27N7O6 (473.20227220000004)

Asn Gly His Phe

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C21H27N7O6 (473.20227220000004)

Asn His Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C17H27N7O7S (473.1692592)

Asn His Phe Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]acetic acid

C21H27N7O6 (473.20227220000004)

Asn His Gly Phe

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-phenylpropanoic acid

C21H27N7O6 (473.20227220000004)

Asn His Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Asn Ile Asn Asn

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Asn Leu Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Asn Asn Ile Asn

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-methylpentanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Asn Asn Leu Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-methylpentanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Asn Asn Asn Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-methylpentanoic acid

C18H31N7O8 (473.2234006)

Asn Asn Asn Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-methylpentanoic acid

C18H31N7O8 (473.2234006)

Asn Asn Gln Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-methylbutanoic acid

C18H31N7O8 (473.2234006)

Asn Asn Val Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-4-carbamoylbutanoic acid

C18H31N7O8 (473.2234006)

Asn Pro Asp Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]pentanedioic acid

C18H27N5O10 (473.17578419999995)

Asn Pro Glu Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-carboxybutanamido]butanedioic acid

C18H27N5O10 (473.17578419999995)

Asn Gln Asn Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C18H31N7O8 (473.2234006)

Asn Gln Val Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Asn Thr Cys His

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Asn Thr His Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Asn Val Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C18H31N7O8 (473.2234006)

Asn Val Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Pro Asp Asp Lys

(2S)-6-amino-2-[(2S)-3-carboxy-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]hexanoic acid

C19H31N5O9 (473.21216760000004)

Pro Asp Asp Gln

(2S)-4-carbamoyl-2-[(2S)-3-carboxy-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid

C18H27N5O10 (473.17578419999995)

Pro Asp Glu Asn

(4S)-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-4-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoic acid

C18H27N5O10 (473.17578419999995)

Pro Asp Gly Trp

(3S)-3-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C22H27N5O7 (473.19103920000003)

Pro Asp Lys Asp

(2S)-2-[(2S)-6-amino-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]hexanamido]butanedioic acid

C19H31N5O9 (473.21216760000004)

Pro Asp Asn Glu

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanedioic acid

C18H27N5O10 (473.17578419999995)

Pro Asp Gln Asp

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]butanedioic acid

C18H27N5O10 (473.17578419999995)

Pro Asp Arg Ser

(3S)-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C18H31N7O8 (473.2234006)

Pro Asp Ser Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxypropanamido]pentanoic acid

C18H31N7O8 (473.2234006)

Pro Asp Trp Gly

(3S)-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C22H27N5O7 (473.19103920000003)

Pro Glu Asp Asn

(4S)-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-carboxyethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C18H27N5O10 (473.17578419999995)

Pro Glu Asn Asp

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-4-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]butanedioic acid

C18H27N5O10 (473.17578419999995)

Pro Glu Gln Thr

(4S)-4-{[(1S)-3-carbamoyl-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}propyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C19H31N5O9 (473.21216760000004)

Pro Glu Thr Gln

(4S)-4-{[(1S,2R)-1-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C19H31N5O9 (473.21216760000004)

Pro Gly Asp Trp

(3S)-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanoic acid

C22H27N5O7 (473.19103920000003)

Pro Gly Trp Asp

(2S)-2-[(2S)-3-(1H-indol-3-yl)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]butanedioic acid

C22H27N5O7 (473.19103920000003)

Pro Lys Asp Asp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-carboxypropanamido]butanedioic acid

C19H31N5O9 (473.21216760000004)

Pro Asn Asp Glu

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-carboxypropanamido]pentanedioic acid

C18H27N5O10 (473.17578419999995)

Pro Asn Glu Asp

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-carboxybutanamido]butanedioic acid

C18H27N5O10 (473.17578419999995)

Pro Gln Asp Asp

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-carboxypropanamido]butanedioic acid

C18H27N5O10 (473.17578419999995)

Pro Gln Glu Thr

(4S)-4-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C19H31N5O9 (473.21216760000004)

Pro Gln Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-hydroxybutanamido]pentanedioic acid

C19H31N5O9 (473.21216760000004)

Pro Arg Asp Ser

(3S)-3-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C18H31N7O8 (473.2234006)

Pro Arg Ser Asp

(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-hydroxypropanamido]butanedioic acid

C18H31N7O8 (473.2234006)

Pro Ser Asp Arg

(2S)-5-carbamimidamido-2-[(2S)-3-carboxy-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanoic acid

C18H31N7O8 (473.2234006)

Pro Ser Arg Asp

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]butanedioic acid

C18H31N7O8 (473.2234006)

Pro Thr Glu Gln

(4S)-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-4-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanoic acid

C19H31N5O9 (473.21216760000004)

Pro Thr Gln Glu

(2S)-2-[(2S)-4-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]pentanedioic acid

C19H31N5O9 (473.21216760000004)

Pro Trp Asp Gly

(3S)-3-[(carboxymethyl)carbamoyl]-3-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoic acid

C22H27N5O7 (473.19103920000003)

Pro Trp Gly Asp

(2S)-2-{2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}butanedioic acid

C22H27N5O7 (473.19103920000003)

Gln Ala Gln Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-4-carbamoylbutanamido]-4-carbamoylbutanoic acid

C18H31N7O8 (473.2234006)

Gln Cys His Ser

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C17H27N7O7S (473.1692592)

Gln Cys Ser His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Gln Asp Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H27N5O10 (473.17578419999995)

Gln Asp Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H27N5O10 (473.17578419999995)

Gln Glu Pro Thr

(4S)-4-[(2S)-2-amino-4-carbamoylbutanamido]-5-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H31N5O9 (473.21216760000004)

Gln Glu Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carboxybutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Gln His Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C17H27N7O7S (473.1692592)

Gln His Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Gln Asn Asn Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-methylbutanoic acid

C18H31N7O8 (473.2234006)

Gln Asn Val Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-methylbutanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Gln Pro Asp Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]butanedioic acid

C18H27N5O10 (473.17578419999995)

Gln Pro Glu Thr

(4S)-4-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C19H31N5O9 (473.21216760000004)

Gln Pro Thr Glu

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]pentanedioic acid

C19H31N5O9 (473.21216760000004)

Gln Gln Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]propanamido]-4-carbamoylbutanoic acid

C18H31N7O8 (473.2234006)

Gln Gln Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carbamoylbutanamido]-4-carbamoylbutanamido]propanoic acid

C18H31N7O8 (473.2234006)

Gln Ser Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Gln Ser His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Gln Thr Glu Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Gln Thr Pro Glu

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H31N5O9 (473.21216760000004)

Gln Val Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Arg Asp Pro Ser

(3S)-3-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C18H31N7O8 (473.2234006)

Arg Asp Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C18H31N7O8 (473.2234006)

Arg Pro Asp Ser

(3S)-3-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C18H31N7O8 (473.2234006)

Arg Pro Ser Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]butanedioic acid

C18H31N7O8 (473.2234006)

Arg Ser Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H31N7O8 (473.2234006)

Arg Ser Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H31N7O8 (473.2234006)

Ser Cys His Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C18H31N7O6S (473.20564260000003)

Ser Cys His Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C17H27N7O7S (473.1692592)

Ser Cys Lys His

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O6S (473.20564260000003)

Ser Cys Gln His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Ser Asp Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C18H31N7O8 (473.2234006)

Ser Asp Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C18H31N7O8 (473.2234006)

Ser His Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]hexanoic acid

C18H31N7O6S (473.20564260000003)

Ser His Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C17H27N7O7S (473.1692592)

Ser His Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-sulfanylpropanoic acid

C18H31N7O6S (473.20564260000003)

Ser His Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Ser Lys Cys His

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O6S (473.20564260000003)

Ser Lys His Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C18H31N7O6S (473.20564260000003)

Ser Pro Asp Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C18H31N7O8 (473.2234006)

Ser Pro Arg Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]butanedioic acid

C18H31N7O8 (473.2234006)

Ser Gln Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Ser Gln His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Ser Arg Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C18H31N7O8 (473.2234006)

Ser Arg Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C18H31N7O8 (473.2234006)

Thr Cys His Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C17H27N7O7S (473.1692592)

Thr Cys Asn His

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Thr Glu Pro Gln

(4S)-4-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-[(2S)-2-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H31N5O9 (473.21216760000004)

Thr Glu Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carboxybutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Thr His Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C17H27N7O7S (473.1692592)

Thr His Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Thr Asn Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O7S (473.1692592)

Thr Asn His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H27N7O7S (473.1692592)

Thr Pro Glu Gln

(4S)-4-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}butanoic acid

C19H31N5O9 (473.21216760000004)

Thr Pro Gln Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]pentanedioic acid

C19H31N5O9 (473.21216760000004)

Thr Gln Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O9 (473.21216760000004)

Thr Gln Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H31N5O9 (473.21216760000004)

Val Asn Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C18H31N7O8 (473.2234006)

Val Asn Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Val Gln Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C18H31N7O8 (473.2234006)

Trp Asp Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C22H27N5O7 (473.19103920000003)

Trp Asp Pro Gly

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C22H27N5O7 (473.19103920000003)

Trp Gly Asp Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C22H27N5O7 (473.19103920000003)

Trp Gly Pro Asp

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetyl}pyrrolidin-2-yl]formamido}butanedioic acid

C22H27N5O7 (473.19103920000003)

Trp Pro Asp Gly

(3S)-3-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C22H27N5O7 (473.19103920000003)

Trp Pro Gly Asp

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}acetamido)butanedioic acid

C22H27N5O7 (473.19103920000003)

CAY10641

1-[2-hydroxy-3-(4-phenoxyphenoxy)propyl]-3-(2-methyl-1-oxopropyl)-1H-indole-5-carboxylic acid

C28H27NO6 (473.18382820000005)

Trp-Phe-OH

(S)-2-(3-(2-(1H-indol-2-yl)ethoxy)-4-nitrobenzamido)-3-phenylpropanoic acid

C26H23N3O6 (473.1586778)

HoPhe-Trp-OH

(S)-3-(1H-indol-3-yl)-2-(4-nitro-3-phenethoxybenzamido)propanoic acid

C26H23N3O6 (473.1586778)

Pteroyl-D-glutamic acid

C20H23N7O7 (473.1658888)

Dhurrin 6'-glucoside

2-(4-hydroxyphenyl)-2-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile

C20H27NO12 (473.15331820000006)

((2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(4-hydroxyphenethoxy)tetrahydro-2H-pyran-2-yl)methyl 2-(2-oxoindolin-3-yl)acetate

C24H27NO9 (473.1685732000001)

Pyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-trione,7-[2-(ethylsulfonyl)ethyl]-6-hydroxy-1,3-dimethyl-9-(phenylmethyl)-

C21H23N5O6S (473.13689780000004)

(1-NAPHTHYL) 2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-BETA-D-GLUCOPYRANOSIDE

C24H27NO9 (473.1685732000001)

NAN-190 hydrobromide

2-(4-(4-(2-METHOXYPHENYL)PIPERAZIN-1-YL)BUTYL)ISOINDOLINE-1,3-DIONE HYDROBROMIDE

C23H28BrN3O3 (473.1313918000001)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists NAN-190 hydrobromide is a serotonin receptor 5-HT antagonist. NAN-190 is a selective antagonist of 5-HT1A[1][3].

E-4031

C21H29Cl2N3O3S (473.1306584)

Fmoc-Asp(O-2-PhiPr)-OH

C28H27NO6 (473.18382820000005)

Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2-methoxyphenyl)-7-methyl- (9CI)

C27H27N3O3S (473.1773032000001)

ketotrexate

C21H27N7O6 (473.20227220000004)

Aluminon

Aurintricarboxylic acid ammonium salt

C22H23N3O9 (473.14342280000005)

Glisamuride

C23H31N5O4S (473.20966460000005)

4-[5-(2-chlorophenyl)-4-[4-(dimethylamino)phenyl]-oxazol-2-yl]-N,N-dipropyl-aniline

C29H32ClN3O (473.2233772)

Cyclazosin hydrochloride

C23H28ClN5O4 (473.1829718000001)

Methyl5-acetamido-4,7,8,9-tetra-O-acetyl-2,6-anhydro-3,5-dideoxy-D-glycero-D-galacto-non-2-enonate

C20H27NO12 (473.15331820000006)

Rosiglitazone maleate

C22H23N3O7S (473.12566480000004)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents Rosiglitazone maleate (BRL 49653C) is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone maleate is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).

Pazopanib Hydrochloride

Pazopanib HCl (GW786034 HCl)

C21H24ClN7O2S (473.14006340000003)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

Sapitinib

C23H25ClFN5O3 (473.1629862)

Fmoc-β-Homo-Tyr(tbu)-OH

C29H31NO5 (473.2202116)

Fmoc-N-Me-Tyr(tBu)-OH

C29H31NO5 (473.2202116)

1-(4-Methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide

C26H27N5O4 (473.20629420000006)

Neratinib Impurity 09

C25H20ClN5O3 (473.1254600000001)

1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 1-(4-ethoxyphenyl)-4,5,6,7-tetrahydro-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-

C26H27N5O4 (473.20629420000006)

Emofolin sodium

C21H27N7O6 (473.20227220000004)

Fmoc-NH-PEG4-CH2COOH

C25H31NO8 (473.2049566)

Simenepag isopropyl

C26H35NO5S (473.2235820000001)

C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent

Mederrhodin A

C24H27NO9 (473.1685732000001)

N-[4-[[(2-Amino-6,7,8,9-tetrahydro-8-methyl-4,9-dioxo-4H-pyrazino[1,2-a]-1,3,5-triazin-7-yl)methyl]amino]benzoyl]-L-glutamic Acid

C20H23N7O7 (473.1658888)

1-[2-[bis[4-(trifluoromethyl)phenyl]methoxy]ethyl]-3,6-dihydro-2H-pyridine-5-carboxylic acid

C23H21F6NO3 (473.1425548000001)

D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D058805 - GABA Uptake Inhibitors D018377 - Neurotransmitter Agents > D018682 - GABA Agents D049990 - Membrane Transport Modulators

PDGF RTK inhibitor

C26H23N3O4S (473.14091980000006)

Benzyl 2-acetamido-2-deoxy-3-O-beta-D-galactopyranosyl-alpha-D-galactopyranoside

C21H31NO11 (473.18970160000003)

2-imino-10-methyl-N-[2-(4-morpholinyl)ethyl]-5-oxo-1-(3-pyridinylmethyl)-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxamide

C25H27N7O3 (473.21752720000006)

leucovorin

Folinic acid

C20H23N7O7 (473.1658888)

D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative D018977 - Micronutrients > D014815 - Vitamins Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1]. Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1].

N-{3-[5-(6-Amino-purin-9-YL)-3,4-dihydroxy-tetrahydro-furan-2-YL]-allyl}-2,3-dihydroxy-5-nitro-benzamide

C19H19N7O8 (473.12950539999997)

5-Hydroxymethylene-6-hydrofolic acid

C20H23N7O7 (473.1658888)

Lixivaptan

C27H21ClFN3O2 (473.1306248)

C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist

Enasidenib

C19H17F6N7O (473.1398704)

[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-[(3S)-3,6-diamino-2,6-dioxohexyl]phosphinic acid

C16H24N7O8P (473.1423914)

Glutaminyl-beta-ketophosphonate-adenosine

C16H24N7O8P (473.1423914)

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(E)-4-methyl-6-(3-methyl-1,4-dioxonaphthalen-2-yl)hex-4-enoyl]oxyoxane-2-carboxylate

C24H25O10- (473.144765)

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-[(4-phenylphenyl)methylsulfanyl]propan-2-yl]amino]-5-oxopentanoic acid

C23H27N3O6S (473.1620482000001)

10-Formyltetrahydropteroylglutamic acid

C20H23N7O7 (473.1658888)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

MeTHHF disodium

C21H27N7O6 (473.20227220000004)

Formyltetrahydrofolate

C20H23N7O7 (473.1658888)

4-[[6-Hydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexa-2,4-dien-1-ylidene]amino]-1,5-dimethyl-2-phenylpyrazol-3-one

C23H27N3O8 (473.17980620000003)

Avandia

C22H23N3O7S (473.12566480000004)

D007004 - Hypoglycemic Agents

Nitrosulindac

C24H24FNO6S (473.1308296)

Platensimycin A5 Methyl Ester

C25H31NO8 (473.2049566)

A polycyclic cage compound that is the methyl ester derivative of the dihydroxy substituted platensimycin. It is isolated from Streptomyces platensis.

Platencin A11 Methyl Ester

C25H31NO8 (473.2049566)

A natural product found in Streptomyces platensis.

N-{4-[{[(6s)-2-Amino-4-Oxo-3,4,5,6,7,8-Hexahydropteridin-6-Yl]methyl}(Formyl)amino]benzoyl}-L-Glutamic Acid

C20H23N7O7 (473.1658888)

N-(3-chlorophenyl)-2-[6,7-dimethoxy-2,4-dioxo-3-(2-oxolanylmethyl)-1-quinazolinyl]acetamide

C23H24ClN3O6 (473.13535540000004)

6-hydroxy platensimycin A1 methyl ester

C24H27NO9 (473.1685732000001)

A natural product found in Streptomyces platensis.

5-[(2-chloro-6-fluorophenyl)methyl]-N-[2-[4-(4-methoxyphenyl)-1-piperazinyl]ethyl]-1,3,4-oxadiazole-2-carboxamide

C23H25ClFN5O3 (473.1629862)

N-(1,3-benzodioxol-5-yl)-1-[4-(4-morpholinylsulfonyl)phenyl]-4-piperidinecarboxamide

C23H27N3O6S (473.1620482000001)

2-(4-propylphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]-4-quinolinecarboxamide

C27H27N3O3S (473.1773032000001)

1,2-dibutyryl-sn-glycero-3-phospho-(1D-myo-inositol)(1-)

C17H30O13P- (473.142396)

A 1-phosphatidyl-1D-myo-inositol(1-) that is the conjugate base of 1,2-dibutyryl-sn-glycero-3-phospho-1D-myo-inositol, obtained by deprotonation of the phosphate OH group; major species at pH 7.3.

1-[2,5-diethoxy-4-(1-tetrazolyl)phenyl]sulfonyl-4-(4-fluorophenyl)-3,6-dihydro-2H-pyridine

C22H24FN5O4S (473.15329560000004)

4-amino-N5-(4-butoxyphenyl)-N5-[2-(cyclohexylamino)-2-oxoethyl]isothiazole-3,5-dicarboxamide

C23H31N5O4S (473.20966460000005)

3-[(2-Chlorophenyl)methyl]-7-[4-[4-(trifluoromethyl)phenyl]-1-piperazinyl]triazolo[4,5-d]pyrimidine

C22H19ClF3N7 (473.13424800000007)

3-(benzenesulfonyl)-N-[2-(diethylamino)ethyl]-N-(4,6-dimethyl-1,3-benzothiazol-2-yl)propanamide

C24H31N3O3S2 (473.18067360000003)

4-[2-[(1-acetyl-4-oxo-6-spiro[3,4-dihydro-2H-1-benzopyran-2,4-piperidine]yl)oxy]-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester

C24H31N3O7 (473.2161896)

Platensimycin A6 Methyl Ester

Glu-Tyr-Tyr

C23H27N3O8 (473.17980620000003)

alpha-D-Galp-(1->4)-beta-D-Galp-O(CH2)2S(CH2)2CONH2

C17H31NO12S (473.15668860000005)

A glycoside that consists of alpha-D-galactosyl-(1->4)-beta-D-galactose having a 2-(2-aminocarbonylethylthio)ethyl moiety attached to the reducing end anomeric centre.

5-O-[(S)-hydroxy(octanoyloxy)phosphoryl]adenosine

C18H28N5O8P (473.16754180000004)

beta-D-Gal-(1->3)-alpha-D-GalNAc-OBn

C21H31NO11 (473.18970160000003)

An amino disaccharide consisting of benzyl 2-acetamido-2-deoxy-D-galactoside having a beta-D-galactosyl residue attached at the 3-position.

OA-6129 B1

C20H31N3O8S (473.1831766)

(6S)-5-formyltetrahydrofolic acid

C20H23N7O7 (473.1658888)

The pharmacologically active (6S)-stereoisomer of 5-formyltetrahydrofolic acid.

(6R)-10-formyltetrahydrofolic acid

C20H23N7O7 (473.1658888)

A 10-formyltetrahydrofolic acid that has R-configuration at position 6.

ST 23:6;O6;Gly

C25H31NO8 (473.2049566)

ST 18:4;O7;Tau

C20H27NO10S (473.1355602000001)

ST 19:3;O6;Tau

C21H31NO9S (473.1719436000001)

ST 20:2;O5;Tau

C22H35NO8S (473.20832700000005)

ST 24:6;O2;Tau

C26H35NO5S (473.2235820000001)

AD80

C22H19F4N7O (473.1587132)

AD80, a multikinase inhibitor, inhibits RET, RAF,SRCand S6K, with greatly reduced mTOR activity.

ALOX15-IN-1

C24H31N3O5S (473.19843160000005)

ALOX15-IN-1 (compound 8b) is a potent inhibitor of the linoleate oxygenase activity of rabbit and human ALOX15 with IC50s of 0.04 and 2.06 μM for ALOX15 0rthologs linoleic acid (LA) and arachidonic acid (AA), respectively[1].

ASN007

C22H25ClFN7O2 (473.1742192)

ASN007 (ERK-IN-3) is a potent and orally active inhibitor of ERK. ASN007 inhibits ERK1/2 with low single-digit nM IC50 values. ASN007 can be used for the research of cancers driven by RAS mutations[1].

CTX-0294885 (hydrochloride)

C22H25Cl2N7O (473.149754)

CTX-0294885 hydrochloride is a broad spectrum kinase inhibitor that can capture 235 kinases from MDA-MB-231 cells, and can capture all members of the AKT family. CTX-0294885 hydrochloride is a powerful reagent for analysis of kinome signaling networks that can be used for the research of diseases like inflammation, diabetes, and cancer[1].

TLK117

C23H27N3O6S (473.1620482000001)

TLK117, the active metabolite of TLK199, selective inhibits Glutathione S-transferase P1–1 (GSTP1-1) with a Ki of 0.4 μM for GSTP. TLK117 also competitively inhibits glyoxalase I with a Ki of 0.56 μM.

(1r,2s,9r,10s,15r)-9,11,11',15-tetrahydroxy-7-methoxy-6'-methyl-3'-oxa-12-azaspiro[tetracyclo[8.3.3.0¹,¹⁰.0³,⁸]hexadecane-2,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),3(8),4,4',6,6',8',10',11-nonaen-13-one

(1r,2s,9r,10s,15r)-9,11,11',15-tetrahydroxy-7-methoxy-6'-methyl-3'-oxa-12-azaspiro[tetracyclo[8.3.3.0¹,¹⁰.0³,⁸]hexadecane-2,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),3(8),4,4',6,6',8',10',11-nonaen-13-one

C27H23NO7 (473.1474448)

n-[2,6-dihydroxy-3-(methoxycarbonyl)phenyl]-3-[(1s,5s,10s)-10-hydroxy-10-(hydroxymethyl)-5-methyl-4-oxotricyclo[7.2.1.0¹,⁶]dodec-2-en-5-yl]propanimidic acid

C25H31NO8 (473.2049566)

(2r,9s,9ar)-9-hydroxy-9-{[(1s,4s)-3-hydroxy-1-isopropyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

C26H27N5O4 (473.20629420000006)

[(2r,3s,4s,5r,6s)-6-{4-[(s)-cyano(hydroxy)methyl]phenoxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C23H23NO10 (473.1321898)

(2s,9s,9ar)-9-hydroxy-9-{[(1r,4r)-3-hydroxy-1-isopropyl-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

C26H27N5O4 (473.20629420000006)

(2s)-2-[(z)-{1-[(2r)-10-acetyl-5,11,13-trihydroxy-2,12-dimethyl-3-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),4,6,10,12-pentaen-4-yl]ethylidene}amino]pentanedioic acid

C23H23NO10 (473.1321898)